Drug Research - Latest News & Updates on Drug Research

Designing Biotech Financial Models for Series B Success

Yuvraj — Mon, 27 Apr 2026 08:43:12 +0000

Building a compelling Series B case in biopharma goes well beyond efficacy data and market size projections. Sophisticated investors are increasingly focused on CMC risk, licensing obligations, and the defensibility of your manufacturing timeline. This article breaks down what the financial model behind a strong Series B actually looks like and what quietly kills deals that should have worked.

The post Designing Biotech Financial Models for Series B Success first appeared on World Pharma Today.

CMC Bottleneck in Drug Development and IND Delays

Yuvraj — Mon, 27 Apr 2026 06:39:46 +0000

Ask any experienced biopharma program manager what derails an IND filing most often, and the answer is rarely surprising: it is CMC. Not insufficient efficacy data, not toxicology surprises CMC. This article examines why Chemistry, Manufacturing, and Controls continues to be the most underestimated risk in early drug development, and what program leaders can do about it.

The post CMC Bottleneck in Drug Development and IND Delays first appeared on World Pharma Today.

The Hidden Cost of Licensing in Biologic Drug Development

Yuvraj — Fri, 24 Apr 2026 10:47:39 +0000

Royalties, milestone payments, and license fees are often treated as the cost of doing business in biopharma. But for early-stage biotech companies building toward an IND, these obligations can quietly reshape financial models, complicate investor conversations, and create downstream deal terms that are difficult to unwind. Here is what founders need to know.

The post The Hidden Cost of Licensing in Biologic Drug Development first appeared on World Pharma Today.

Early Phase Decisions Drive Faster Drug Development

Yuvraj — Thu, 23 Apr 2026 06:13:33 +0000

Strategic early-stage planning and rigorous regulatory readiness serve as the foundation for accelerating pharmaceutical timelines and optimizing long-term R&D efficiency.

The post Early Phase Decisions Drive Faster Drug Development first appeared on World Pharma Today.

Smarter Trial Design Improves Drug Development Speed

Yuvraj — Wed, 22 Apr 2026 11:46:47 +0000

Optimization of clinical trial protocols through innovative designs and strategic endpoint selection directly accelerates drug development speed and improves operational reliability.

The post Smarter Trial Design Improves Drug Development Speed first appeared on World Pharma Today.

Data Driven Decisions Improve Drug Development Outcomes

Yuvraj — Wed, 22 Apr 2026 11:43:21 +0000

Integrating comprehensive analytics and real-world data into clinical planning allows pharmaceutical companies to optimize trial design and significantly improve patient outcomes.

The post Data Driven Decisions Improve Drug Development Outcomes first appeared on World Pharma Today.

Efficient Early Strategies Enable Faster Clinical Progress

Yuvraj — Wed, 22 Apr 2026 11:31:19 +0000

Implementing optimized early-stage frameworks and enhancing trial readiness allows pharmaceutical sponsors to accelerate clinical timelines and maintain high R&D efficiency.

The post Efficient Early Strategies Enable Faster Clinical Progress first appeared on World Pharma Today.

Early Insights Reduce Risk in Drug Development Programs

Yuvraj — Wed, 22 Apr 2026 11:10:42 +0000

Leveraging early-stage data and translational research allows pharmaceutical companies to mitigate drug development risk and implement adaptive strategies for higher success.

The post Early Insights Reduce Risk in Drug Development Programs first appeared on World Pharma Today.

Boehringer Ingelheim Launches New AI R&D Centre in London

Yuvraj — Tue, 21 Apr 2026 13:39:53 +0000

Boehringer Ingelheim has introduced a new artificial intelligence (AI) and machine learning (ML) facility in London, strengthening its efforts to integrate advanced technologies into pharmaceutical research. The AI R&D centre will focus on applying AI models to support the discovery and development of targeted medicines, particularly for patients with unmet medical needs. Located in King’s […]

The post Boehringer Ingelheim Launches New AI R&D Centre in London first appeared on World Pharma Today.

PacBio, Covaris Advance HiFi Sequencing Workflow for FFPE

Yuvraj — Fri, 17 Apr 2026 06:09:06 +0000

A new integrated approach to long-read sequencing of archived tissue samples has been introduced through a collaboration between PacBio and Covaris, with the workflow set to be presented at the American Association for Cancer Research Annual Meeting. The jointly developed solution combines Covaris’ extraction capabilities with PacBio’s sequencing technologies to enable a seamless transition from […]

The post PacBio, Covaris Advance HiFi Sequencing Workflow for FFPE first appeared on World Pharma Today.